Company Overview of Alnylam Pharmaceuticals, Inc.
Phillip A. Sharp Ph.D.
Co-Founder, Director & Member of the Scientific Advisory Board, Alnylam Pharmaceuticals, Inc.
|Age||Total Calculated Compensation||This person is connected to 12 Board Members in 12 organization across 10 different industries.|
See Board Relationships
300 Third StreetPhone: 617-551-8200
Cambridge, Massachusetts 02142
Board Members Memberships
Director and Member of Strategic Advisory Board
Co-Founder, Director & Member of the Scientific Advisory Board
Member of Scientific Advisory Board & Director
University of Illinois-Urbana-Champaign
Annual CompensationThere is no Annual Compensation data available.
Stocks OptionsThere is no Stock Options data available.
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
|Andrew Rackear J.D.||CEO & Secretary|
Enzon Pharmaceuticals, Inc.
|Pascal Soriot||CEO & Executive Director|
|Douglas S. Ingram J.D., Esq.||President, CEO & Director|
Sarepta Therapeutics, Inc.
|Douglas M. Fambrough III, Ph.D.||Co-Founder, Chief Executive Officer, President and Director|
Dicerna Pharmaceuticals, Inc.
|William Stuart Marshall Ph.D.||Co-Founder, Chief Executive Officer, President and Director|
Miragen Therapeutics, Inc.
|$340.0K||Compensation as of Fiscal Year 2016.|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.